IV Thrombolysis Time Window Limitations

Introduction to Time-Sensitive Treatment

The American Heart Association and American Stroke Association recommend IV tPA within 3 hours of symptom onset as the primary treatment window, based on the NINDS trials showing 30% improvement in functional outcomes 1, 2
The European Cooperative Acute Stroke Study (ECASS) III and subsequent guidelines support an extended window up to 4.5 hours, though with more stringent exclusion criteria (age >80 years, NIHSS >25, diabetes plus prior stroke, or anticoagulant use regardless of INR) 3, 4

Beyond 4.5 hours, mortality increases significantly with an odds ratio of 1.49 (95% CI 1.0-2.21) and no proven functional benefit (OR 1.22, 95% CI 0.96-1.54) 3
Symptomatic intracranial hemorrhage occurs in 6.4% within 3 hours but increases substantially with delayed treatment 1, 5

The American College of Cardiology recommends initiating anticoagulation for atrial fibrillation after excluding hemorrhage on imaging, as this addresses the underlying cardioembolic mechanism 5
The American Heart Association recommends transferring patients to a dedicated stroke unit immediately to reduce mortality and dependency 5
The American Stroke Association suggests beginning rehabilitation assessment within 48 hours once medically stable 5
Maintaining blood pressure control with systolic <180 mmHg and diastolic <105 mmHg is recommended to prevent hemorrhagic transformation of the established infarct 5